Dinner Symposium - Time for Action: The Urgent Need for Immunization in Patients with IBD

Dinner Symposium - Time for Action: The Urgent Need for Immunization in Patients with IBD

National Meeting
Program Details

Monday, October 8, 2018

Registration/Dinner: 7:00 PM - 7:30 PM

Educational Session: 7:30 PM - 9:00 PM

Philadelphia Marriott Downtown
Grand Ballroom Salons J-H
5th Floor

Philadelphia, Pennsylvania

Live Complimentary CME-accredited Interactive Dinner Symposium.

CLICK HERE to Register

Registration is for planning purposes only and seating will be available on a first come, first served basis.

Chair

Millie D. Long, MD, MPH, FACG
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty

Francis A. Farraye, MD, MSc, FACG
Boston Medical Center
Boston University School of Medicine
Boston, Massachusetts
 
Gil Y. Melmed, MD, MS, FACG
Cedars-Sinai Medical Center
Los Angeles, California

 

 

 

Agenda
7:00 PM Registration
7:30 PM Welcome, pre-activity learner survey via audience response system (ARS)
  Millie D. Long, MD, MPH, FACG
7:35 PM Vaccination guidelines and recommendations in IBD
  Gil Y. Melmed, MD, MS, FACG
8:00 PM Emerging therapies and immunizations for IBD patients
  Francis Farraye, MD, MSc, FACG
8:20 PM Case #1: Preventive care needs in a young IBD patient
  Millie D. Long, MD, MPH, FACG
8:30 PM Case #2: Preventive care needs in an older adult IBD patient
  Millie D. Long, MD, MPH, FACG
8:40 PM Audience and panel discussion: strategies to optimize patient education/adherence to vaccination
8:55 PM Closing remarks, a recap of key messages, and post-activity learner survey via ARS
  Millie D. Long, MD, MPH, FACG
9:00 PM Adjournment
Intended Learners

This activity is designed for gastroenterology physicians, internists, fellows, gastroenterology nurses, and related healthcare providers attending the ACG 2018 Annual Scientific Meeting that are involved and/or interested in the therapeutic management of patients with IBD will also benefit from the education.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify vaccination recommendations for patients with IBD on low-level and high-level immunosuppression therapy, as per guidelines
  • Evaluate strategies to ensure that every patient with IBD has had a review of immunization status and that all appropriate vaccinations are current
  • Demonstrate the use of tools to establish a coordinated care practice with primary care clinicians for all patients with IBD to ensure vaccinations are up-to-date
  • Provide education for all patients with IBD on the importance of immunization
Activity Overview

This interactive dinner symposium will occur in Grand Ballroom - Salons H-J of the Philadelphia Marriott Downtown on Monday, October 8, from 7:00 pm to 9:00 pm. A question-and-answer session with the faculty will follow the presentation.

To be eligible for documentation of credit, participants must attend the live activity and submit a completed evaluation form.  All individuals who participate in the full symposium and submit a hard-copy evaluation will receive documentation of credit via email within 8 weeks.

For questions regarding this educational activity, please call (800) 233-0957.

No additional fee is required to attend this activity.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and  Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Save

Save

Save

Save

Save

Save

Save

Save

CME

NACCME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.50 contact hours.

CPE

This knowledge-based activity (JA0006201-9999-18-185-L01-P) is approved for 1.50 contact hours (0.015 CEUs) of continuing pharmacy education. Participants must attend sessions and complete an evaluation in order to claim credit. Participants will have only 60 days following the activity to claim credit (Deadline: December 8, 2018.)

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

Planning Committee

The planning committee comprises Francis A. Farraye, MD, MSc, FACG, Millie D. Long, MD, MPH, FACG, Gil Melmed, MD, FACG; and Chris Bolwell, Monalisa Singh, and Susan Yarbrough, Imedex.


Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Faculty disclosures will be provided prior to the activity

Chris Bolwell discloses that he holds shares of stock of GlaxoSmithKline.

Monalisa Singh and Susan Yarbrough disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

Disclosure of off-label/unapproved uses of drugs and/or devices will be provided prior to the symposium.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity has been supported by an educational grant from Pfizer, Inc.